NHL, ADULT

Clinical trials for NHL, ADULT explained in plain language.

Never miss a new study

Get alerted when new NHL, ADULT trials appear

Sign up with your email to follow new studies for NHL, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New CAR T-Cell therapy SynKIR-310 enters first human trial for Tough-to-Treat lymphoma

Disease control Recruiting now

This early-phase study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to target and attack cancer cells. The main go…

Matched conditions: NHL, ADULT

Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

NHL, ADULT

Get alerted when new NHL, ADULT trials appear

New CAR T-Cell therapy SynKIR-310 enters first human trial for Tough-to-Treat lymphoma